Elevated Capital Advisors’s Organon & Co OGN Stock Holding History
Bought
Maintained
Sold
Other funds holding OGN
Elevated Capital Advisors's OGN Position: Q3 2026 in Review
Elevated Capital Advisors held its Organon & Co (OGN) position steady in Q3 2026 at 40 shares worth $549. The position accounts for ﹤0.01% of the portfolio, ranked #812.
Elevated Capital Advisors first reported a position in OGN in Q4 2025 and has held it in 4 quarters since. 268 funds tracked by Wall St. Rank hold OGN as of Q3 2026.
- Elevated Capital Advisors held 40 shares of Organon & Co worth $549 as of Q3 2026.
- Elevated Capital Advisors left its Organon & Co share count unchanged in Q3 2026.
- Organon & Co made up ﹤0.01% of Elevated Capital Advisors's portfolio in Q3 2026, its #812 holding.
- Elevated Capital Advisors first reported a position in Organon & Co in Q4 2025 and has held it in 4 quarters since.
- 268 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.
Based on Elevated Capital Advisors's 13F filing for Q3 2026, filed 4 Nov 2026.